Ticker Details
Eton Pharmaceuticals, Inc. Common Stock
IPO Date:	November 13, 2018
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$1.02B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.26 | 3.15%
Avg Daily Range (30 D):	$0.78 | 2.39%
Avg Daily Range (90 D):	$0.82 | 3.08%

Institutional Daily Volume
Avg Daily Volume:	.2M
Avg Daily Volume (30 D):	.31M
Avg Daily Volume (90 D):	.34M

Trade Size
Avg Trade Size (Sh.):	109
Avg Trade Size (Sh.) (30 D):	52
Avg Trade Size (Sh.) (90 D):	56

Institutional Trades
Total Institutional Trades:	180
Avg Institutional Trade:	$1.6M
Avg Institutional Trade (30 D):	$2.36M
Avg Institutional Trade (90 D):	$1.6M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.7M
Avg Closing Trade (30 D):	$2.24M
Avg Closing Trade (90 D):	$1.54M
Avg Closing Volume:	94.72K

News

Mar 2, 2026 @ 12:27 PM Eton Pharmaceuticals Expands Rare Disease Portfoli... Source: Globe Newswire

Feb 25, 2026 @ 6:47 PM Eton Pharmaceuticals Announces U.S. FDA Approval f... Source: Na

May 9, 2024 @ 8:01 PM Eton Pharmaceuticals Reports First Quarter 2024 Fi... Source: Eton Pharmaceuticals

May 1, 2024 @ 8:05 PM Eton Pharmaceuticals to Present at the Citizens JM... Source: Eton Pharmaceuticals

Apr 30, 2024 @ 11:00 AM Eton Pharmaceuticals Announces Submission to FDA o... Source: Eton Pharmaceuticals

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.06	$.06	$-.17
Diluted EPS	$.05
Revenue	$24.27M	$21.28M	$79.95M
Gross Profit	$14.74M	$13.1M	$42.74M
Net Income / Loss	$1.55M	$1.48M	$-4.6M
Operating Income / Loss	$2.41M	$2.46M	$-.84M
Cost of Revenue	$9.53M	$8.18M	$37.21M
Net Cash Flow	$-6.28M	$-11.18M	$11.01M
PE Ratio